The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,937
Sort by:
Beta Thalassemia Market - 2026-2033
US$ 3,400.00
Beta Thalassemia Market reached US$ 560.97 million in 2025 and is expected to reach US$ 1,038.73 million by 2033, growing with a CAGR of 8.10% during the forecast period 2026-2033. The Beta Thalassemi...
May 2026
42 pages
Pain Relief Medication Market - 2026-2033
US$ 3,400.00
Pain Relief Medication Market reached USD 84.48 billion in 2025 and is expected to reach USD 128.86 billion by 2033, growing with a CAGR of 5.60% during the forecast period 2026-2033. The Pain Relief...
May 2026
48 pages
Beri Beri Treatment Market - 2026-2033
US$ 3,400.00
Beri Beri Treatment Market reached USD 276.26 million in 2025 and is expected to reach USD 718.85 million by 2035, growing with a CAGR of 7.00% during the forecast period 2026-2035. The Beri Beri Trea...
May 2026
45 pages
Neutropenia Treatment Market - 2026-2033
US$ 3,400.00
Neutropenia Treatment Market reached USD 16.25 billion in 2025 and is expected to reach USD 26.46 billion by 2033, growing with a CAGR of 5.60% during the forecast period 2026-2033. The Neutropenia Tr...
May 2026
47 pages
Pellagra Treatment Market - 2026-2033
US$ 3,400.00
Pellagra Treatment Market reached USD 56.26 million in 2025 and is expected to reach USD 96.60 million by 2033, growing with a CAGR of 6.80% during the forecast period 2026-2033. The Pellagra Treatmen...
May 2026
44 pages
Porphyria Treatment Market - 2026-2033
US$ 3,400.00
Porphyria Treatment Market reached USD 1.26 billion in 2025 and is expected to reach USD 2.56 billion by 2033, growing with a CAGR of 9.20% during the forecast period 2026-2033. The Porphyria Treatmen...
May 2026
45 pages
Sarcopenia Treatment Market - 2026-2033
US$ 3,400.00
Sarcopenia Treatment Market reached USD 3.36 billion in 2025 and is expected to reach USD 5.56 billion by 2033, growing with a CAGR of 5.80% during the forecast period 2026-2033. The Sarcopenia Treatm...
May 2026
46 pages
Chronic Pain Treatment Market - 2026-2033
US$ 3,400.00
Chronic Pain Treatment Market reached US$ 55.94 billion in 2025 and is expected to reach US$ 140 billion by 2033, growing with a CAGR of 7.80% during the forecast period 2026-2033. The Chronic Pain Tr...
May 2026
48 pages
Intra-Dialytic Hypotension (IDH) Market - 2026-2033
US$ 3,400.00
Intra-Dialytic Hypotension (IDH) Marketis is growing with a CAGR of 9.60% during the forecast period 2026-2035. The Intra-Dialytic Hypotension (IDH) Market emerges as a key focus in DataM Intelligence...
May 2026
58 pages
Enclomiphene Market Size, Share & Trends Analysis Report By Product Type (Enclomiphene Citrate Tablets), By Dosage Strength (Medium Dose (12.5 mg - 25 mg)), By Indication, By Distribution Channel, By Region (North America, Europe, Asia Pacific, Middle East & Africa), And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Enclomiphene Market The global enclomiphene market size was estimated at USD 216.00 million in 2025 and is projected to reach USD 419.05 million by 2033, growing at a CAGR of 8.70% from 2026 to 2033....
May 2026
150 pages
Global Curative Therapeutics Market - 2026-2033
US$ 3,400.00
Global Curative Therapeutics Market reached US$ 21.83 Billion in 2025 and is expected to reach US$ 44.95 Billion by 2033, growing with a CAGR of 9.50% during the forecast period 2026-2033. The Global...
May 2026
54 pages
Anti-senescence Therapeutics Market - 2026-2033
US$ 3,400.00
Anti-senescence Therapeutics Market reached US$ 33.03 billion in 2025 and is expected to reach US$ 53.39 billion by 2033, growing with a CAGR of 6.70% during the forecast period 2026-2033. The Anti-se...
May 2026
54 pages
Longevity And Wellness Pharmaceutical Market Size, Share & Trends Analysis Report By Type (Small Molecule Pharmaceutical Drugs, Biologics & Advanced Therapeutics, Nutraceuticals & Non-Prescription Longevity Compounds), By Therapeutic Application, By Route of Administration, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Longevity And Wellness Pharmaceutical Market The global longevity and wellness pharmaceutical market size was estimated at USD 63,400.00 million in 2025 and is projected to reach USD 106,008.42 millio...
May 2026
150 pages
Mucopolysaccharidoses Market - 2026-2033
US$ 3,400.00
Mucopolysaccharidoses Market reached US$ 2,486.6 million in 2025 and is expected to reach US$ 4,389.85 million by 2033, growing with a CAGR of 7.50% during the forecast period 2026-2033. The Mucopolys...
May 2026
47 pages
Europe Cannabidiol Market Size, Share & Trends Analysis Report By Source (Hemp Derived CBD, Marijuana Derived CBD), By Product, Pharmaceutical-grade CBD), By Application, By Formulation, By Distribution Channel, By Country, And Segment Forecasts, 2026 - 2033
US$ 4,950.00
Europe Cannabidiol Market The Europe cannabidiol market size was estimated at USD 2.3 billion in 2025 and is projected to reach USD 6.0 billion by 2033, growing at a CAGR of 12.7% from 2026 to 2033. T...
May 2026
80 pages
Active Pharmaceutical Ingredient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Synthesis (Biotech, Fermentation, Plant Extracts, Synthetic), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Active Pharmaceutical Ingredient (API) Market is anticipated to expand from USD 160.91 billion in 2025 to USD 241.21 billion by 2031, exhibiting a compound annual growth rate of 6.98%. APIs...
May 2026
177 pages
Intravenous Iron Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Iron Dextran, Ferric Gluconate, Iron Sucrose, Ferric Carboxymaltos, Iron Isomaltoside 1000, Ferumoxytol), By Application (Intestinal Malabsorption Syndromes, Inflammatory Diseases, Gastrectomy/Bariatric Surgery, Anemia, Osier-Weber-Rendu Disease, Angiodysplasia, Pregnancy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Intravenous Iron Drugs Market is anticipated to expand from USD 2.55 billion in 2025 to USD 3.57 billion by 2031, reflecting a compound annual growth rate (CAGR) of 5.77%. Administered dire...
May 2026
185 pages
Oral Clinical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Alzheimer’s, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others), By Distribution Channel (Direct Sales v/s Indirect Sales), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Oral Clinical Nutrition Market is anticipated to expand from USD 16.96 Billion in 2025 to USD 23.91 Billion by 2031, reflecting a compound annual growth rate of 5.89%. This sector involves...
May 2026
185 pages
Plant Based Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Others), By Application (Binders & Diluents, Glidants, Lubricants & Disintegrants, Film Forming & Coating Agents, Plasticizers, Suspending Agents, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Plant Based Excipients Market is anticipated to expand from USD 2.41 Billion in 2025 to USD 3.11 Billion by 2031, representing a compound annual growth rate (CAGR) of 4.34%. Derived from na...
May 2026
189 pages
Osteoporosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Oral, Injectables, Others), By Drug Type (Parathyroid Hormone Therapy, Bisphosphonates, Calcitonin, Selective Estrogen Receptor Modulators, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global market for osteoporosis medications is expected to expand from USD 14.33 billion in 2025 to USD 18.38 billion by 2031, reflecting a compound annual growth rate of 4.24%. These pharmaceutica...
May 2026
180 pages
Clinical Nutrition Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Oral, Intravenous), By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clinical Nutrition Market is anticipated to expand from USD 34.09 billion in 2025 to USD 48.38 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.01%. This market involve...
May 2026
180 pages
Remdesivir Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dosage Form (Lyophilized Solution, Frozen Solution), By Route of Administration (Intravenous, Inhalation), By Patient Age (Geriatric, Adult, Pediatric), By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV), By Distribution Channel (Hospitals, Clinics, Drug Stores and Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Remdesivir market is anticipated to expand from USD 4.92 billion in 2025 to USD 7.07 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.23%. Sold under the brand name Vek...
May 2026
180 pages
Celiac Disease Drugs Market - 2026-2033
US$ 3,400.00
Celiac Disease Drugs Marketis is growing with a CAGR of 11.40% during the forecast period 2026-2035. The Celiac Disease Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analys...
April 2026
46 pages
Metabolic Disorder Therapeutics Market - 2026-2033
US$ 3,400.00
Metabolic Disorder Therapeutics Marketis is growing with a CAGR of 8.60% during the forecast period 2026-2035. The Metabolic Disorder Therapeutics Market emerges as a key focus in DataM Intelligence l...
April 2026
57 pages
Global Dual GLP-1R/GIPR Agonist Market Growth 2026-2032
US$ 3,660.00
The global Dual GLP-1R/GIPR Agonist market size is predicted to grow from US$ 29966 million in 2025 to US$ 64976 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032. In 2025,...
April 2026
94 pages
Global Medical Electrolytes Market Growth 2026-2032
US$ 3,660.00
The global Medical Electrolytes market size is predicted to grow from US$ 11000 million in 2025 to US$ 16900 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032. Medical Electr...
April 2026
139 pages
Acute On Chronic Liver Failure (ACLF) Market - 2026-2033
US$ 3,400.00
Acute On Chronic Liver Failure (ACLF) Market reached US$ 4.42 billion in 2025 and is expected to reach US$ 6.52 billion by 2033, growing with a CAGR of 6.00% during the forecast period 2026-2033. The...
April 2026
63 pages
Hunter Syndrome Treatment Market - 2026-2033
US$ 3,400.00
Hunter Syndrome Treatment Marketis is growing with a CAGR of 7.50% during the forecast period 2026-2035. The Hunter Syndrome Treatment Market emerges as a key focus in DataM Intelligence latest in-dep...
April 2026
51 pages
Lactose Intolerance Market - 2026-2033
US$ 3,400.00
Lactose Intolerance Market reached US$ 26.2 billion in 2025 and is expected to reach US$ 45.4 billion by 2033, growing with a CAGR of 7.10% during the forecast period 2026-2033. The Lactose Intoleranc...
April 2026
45 pages
Global Glaucoma Therapeutics Market - 2026-2033
US$ 3,400.00
Global Glaucoma Therapeutics Market reached US$ 7.25 Billion in 2025 and is expected to reach US$ 9.97 Billion by 2033, growing with a CAGR of 4.10% during the forecast period 2026-2033. The Global Gl...
April 2026
54 pages
Drug Discount Card Market Forecasts to 2034 – Global Analysis By Type (Pharmacy Benefit Managers (PBMs), Retail Pharmacy Chains, Direct-to-Consumer Platforms, Non-Profit Organizations and Other Types), By Therapeutic Category (Cardiovascular Drugs, Diabetes Drugs, Pain Medications and Other Therapeutic Categories), By Sales Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Drug Discount Card Market is accounted for $36.0 million in 2026 and is expected to reach $76.1million by 2034 growing at a CAGR of 9.8% during the forecast pe...
April 2026
200 pages
Dupuytren Disease Market Forecasts to 2034 – Global Analysis By Disease Type (Type I, Type II and Type III), Treatment (Needle Aponeurotomy, Surgery, Enzyme Injection, Radiation Therapy, Steroid Shot, Occupational Therapy and Other Treatments), Diagnosis, Route of Administration, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Dupuytren Disease Market is accounted for $5.3 billion in 2026 and is expected to reach $8.9 billion by 2034 growing at a CAGR of 6.6% during the forecast peri...
April 2026
200 pages
Muscle Relaxant Drug Market Forecasts to 2034 – Global Analysis By Drug Type (Neuromuscular Blocking Agents, Skeletal Muscle Relaxant Drugs and Facial Muscle Relaxant Drugs), Dosage Form (Capsule, Tablet, Liquid, Sprays and Gel and Ointments), Route Of Administration, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Muscle Relaxant Drug Market is accounted for $4.7 billion in 2026 and is expected to reach $7.6 billion by 2034 growing at a CAGR of 6.3% during the forecast p...
April 2026
200 pages
Myasthenia Gravis Disease Treatment Market Forecasts to 2034 – Global Analysis By Type (Generalized Myasthenia Gravis, Ocular Myasthenia Gravis, Transient Neonatal Myasthenia Gravis and Other Types), Drug Class (Cholinesterase Inhibitors, Monoclonal Antibodies, Corticosteroids, Immunosuppressants, Intravenous Immunoglobulins and Other Drug Classes), Treatment Modality, Distribution Channel and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Myasthenia Gravis Treatment Market is accounted for $2.8 billion in 2026 and is expected to reach $5.4 billion by 2034 growing at a CAGR of 8.5% during the for...
April 2026
200 pages
Paresthesia Treatment Market Forecasts to 2034 – Global Analysis By Type (Chronic Paresthesia, Acute Paresthesia and Other Types), Treatment (Tropical Creams, Anticonvulsants, Immunosuppressant, Antivirals and Other Treatments), Cause, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Paresthesia Treatment Market is accounted for $6.3 billion in 2026 and is expected to reach $9.8 billion by 2034 growing at a CAGR of 5.6% during the forecast...
April 2026
200 pages
Paronychia Treatment Market Forecasts to 2034 – Global Analysis By Product (Mupirocin Ointment, Gentamicin Ointment, Fusidic Acid Ointment, Dicloxacillin and Other Products), Type (Chronic Paronychia, Acute Paronychia, Pyogenic Paronychia, Candidal Paronychia and Other Types), End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Paronychia Treatment Market is accounted for $660.6 million in 2026 and is expected to reach $1335.8 million by 2034 growing at a CAGR of 9.2% during the forec...
April 2026
200 pages
Turner Syndrome Market Forecasts to 2034 – Global Analysis By Type (Mosaic Turner Syndrome and Classical Turner Syndrome), Drug Type (Oxandrolone, Oxandrin, Norditropin, Somatropin, Genotropin, Humatrope, Zomacton and Nutropin), Therapy Type, Diagnosis, Route Of Administration, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Turner Syndrome Market is accounted for $5.3 billion in 2026 and is expected to reach $9.8 billion by 2034 growing at a CAGR of 8.1% during the forecast period...
April 2026
200 pages
Urinary Tract Infection Market Forecasts to 2034 – Global Analysis By Product (Azoles and Amphotericin B, Cephalosporin, Nitrofurans, Penicillin and Combinations, Quinolones and Other Products), Treatment Type, Test Type, Indication, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Urinary Tract Infection Market is accounted for $8.2 billion in 2026 and is expected to reach $14.9 billion by 2034 growing at a CAGR of 7.67% during the forec...
April 2026
200 pages
Anaphylaxis Treatment Market - 2026-2033
US$ 3,400.00
Anaphylaxis Treatment Marketis is growing with a CAGR of 6.00% during the forecast period 2026-2035. The Anaphylaxis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analy...
April 2026
47 pages
